LIVERFASt™ IS REIMBURSED UNDER CPT CODE: 0166U

LIVERFASt™ aids clinicians in the assessment of patients’ liver fibrosis, inflammatory activity and steatosis with one simple blood draw.

Suitable for patients living with Non-Alcoholic Fatty Liver Disease (NAFLD) and Chronic Hepatitis B and Chronic Hepatitis C.

Medicare (Part B)

$0 out-of-pocket cost for the PLA.

Medicare Advantage

Typically $0 out of pocket for the PLA. Some plans have a coinsurance usually under $100.

Commercial Insurance

Plans vary, but you may be expected to cover a portion of the cost. Contact us to learn more about your coverage.

Medicare (Part B)

If you are unsure that you have met your deductible, please contact us or your insurance directly.

Medicare (Part B)

$0 out-of-pocket cost for the PLA.

Medicare Advantage

Typically $0 out of pocket for the PLA. Some plans have a coinsurance usually under $100.

Commercial Insurance

Plans vary, but you may be expected to cover a portion of the cost. Contact us to learn more about your coverage.

Medicare (Part B)

If you are unsure that you have met your deductible, please contact us or your insurance directly.

Physican prescribes LIVERFASt™ for the patients

Patient has lab work done

Using AI, biomarker results are combined with our proprietary algorithm to produce LIVERFASt™ results to customer portal

Results are available fast

Physican prescribes LIVERFASt™ for the patients

Patient has lab work done

Using AI, biomarker results are combined with our proprietary algorithm to produce LIVERFASt™ results to customer portal

Results are available fast

Learn how to incorporate into your clinic